Covaxin output cycle may hit Centre’s deadline

Amid claims by the Centre that “all Indians” can be vaccinated by the yr finish, Bharat Biotech, the producer of Covaxin, has disclosed that it takes 120 days — or about 4 months — for a manufactured batch of vaccines to be launched for provide. “Thus, production batches of Covaxin that were initiated during March this year will be ready for supply only during the month of June,” the corporate mentioned in an announcement on Friday.

So far about between 2-2.5 crore doses of Covaxin have reportedly been provided.

Also learn | WHO nod for Covaxin doubtless in July-September: Bharat Biotech

Earlier this month, V.K. Paul, who heads India’s National Empowered Group on Vaccines said that 216 crore doses of vaccine can be out there by December.

Nearly 60%, or about 130 crore and sufficient to inoculate each Indian as soon as, is premised on quantum jumps within the provide of the 2 vaccines Covishield and Covaxin, with 50-55 crore of the latter.

According to an announcement from the Department of Biotechnology on April 15, Bharat Biotech is to scale up manufacturing to 6-7 crore doses a month from July-August and 10 crore doses, a month from September. This works out to a minimum of 52 crore doses from July-Dec, of which 40 crore is marked out from September-December.

Also learn | India to push for Covaxin recognition by WHO and EU

However, from what Bharat Biotech has said concerning the time lag between manufacturing and provide, it seems this tranche may need to be excluded for this calendar yr.

The Centre has administered 2.1 crore doses as of Friday and, together with doses of Covaxin within the pipeline, has acquired 3.1 crore doses from Bharat Biotech for the reason that vaccine drive started in January. It had acquired a committment for an additional 1 crore by June finish, the Health Ministry mentioned on Friday.

The authorities has positioned an order for 7.5 crore doses to date of Covaxin, in response to a Right To Information request response from the Health Ministry to activist Kanhaiya Kumar on Friday. If the requirement of about 4 crore is fulfilled by June, that also leaves a niche of about 3.5 crore doses.

Also learn | ICMR to get royalty from Covaxin sale

Thus if the expanded manufacturing of July-August (12 crore) numbers (to be out there in November and December) are clubbed, that works out to fifteen.5 crore being out there for the yr, which is about 30% of Dr Paul’s estimate.

“The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP (Standard Operating Procedures of Good Manufacturing Practices). There is a four-month lag time for COVAXIN to translate into actual vaccination,” the corporate mentioned.

All vaccines provided in India are to be submitted for testing and launch to the Central Drugs Laboratory, Government of India. It takes two days for vaccine provides to achieve the depots of the State and Central governments from Bharat Biotech’s services and from there, they’re additional distributed by the State governments to varied districts. This requires extra variety of days. From right here on, vaccines are administered on the designated vaccination centres.

Also learn | Bharat Biotech commences direct provide of COVID-19 vaccine Covaxin to 14 States

Secretary, Department of Biotechnology Renu Swarup mentioned that whereas it might take almost 4 months for a batch of vaccine to be ready, the federal government ready its estimate based mostly on what the producer had dedicated to produce to the federal government.

“Vaccine manufacturing is time consuming and complex. But if, as Dr. Paul has said, a certain number of doses would be available in a particular month, it accounts for the time taken to produce it,” she informed . “However we have to be optimistic about production and musn’t forget that these are companies with long experience in vaccine production.”

India is at present grappling with a scarcity of vaccines and solely about 11% of the inhabitants has acquired a minimum of one dose. India has relaxed rules to permit any established COVID-vaccine maker to produce vaccines, although few such offers have materialised. As of Friday, greater than 22.46 crore vaccine doses had been provided to States and Union Territories. Of this, the entire consumption, together with wastages was 20.46 crore doses as per Health Ministry information. More than 1.84 crore COVID vaccine doses remained with States to be administered.